Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).

Préta LH, Contejean A, Salvo F, Treluyer JM, Charlier C, Chouchana L

Open source

DOI
10.1111/bcp.15280
Published
2022 Jul
Container
British journal of clinical pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcp.15280,
  title = {Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).},
  author = {Préta LH and Contejean A and Salvo F and Treluyer JM and Charlier C and Chouchana L},
  year = {2022},
  journal = {British journal of clinical pharmacology},
  doi = {10.1111/bcp.15280},
  url = {https://doi.org/10.1111/bcp.15280}
}

RIS

TY  - JOUR
TI  - Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
AU  - Préta LH
AU  - Contejean A
AU  - Salvo F
AU  - Treluyer JM
AU  - Charlier C
AU  - Chouchana L
PY  - 2022
JO  - British journal of clinical pharmacology
DO  - 10.1111/bcp.15280
UR  - https://doi.org/10.1111/bcp.15280
ER  - 

APA

LH, P., A, C., F, S., JM, T., C, C., & L, C. (2022). Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).. British journal of clinical pharmacology. https://doi.org/10.1111/bcp.15280

Source records